Virology News and Research

Latest Virology News and Research

DEK gene present in plasma can help predict outcomes for patients with head and neck cancer

Researchers at the University of Cincinnati have discovered that a human cancer-causing gene, called DEK, can be detected in the plasma of head and neck cancer patients. DEK may help doctors understand how a person's immune system could be used to treat cancer or predict outcomes for patients.

18 Feb 2016

Revealing dynamic protein complexes with NMR: an interview with Elisar Barbar

Most proteins are involved in interactions with one or a few functional ligands, but some proteins, like light chain 8 (LC8), have numerous binding partners. LC8 interacts with more than 100 functionally different proteins, from viral proteins to motor proteins to proteins involved in cell division.

From Bruker BioSpin - NMR, EPR and Imaging 18 Feb 2016

Zika virus can cross the placental barrier, according to new study

A study of pregnant women in Brazil has confirmed the presence of Zika virus in the amniotic fluid of two women who had displayed Zika-like symptoms during their pregnancies.

18 Feb 2016

Sanford Health clinical trial testing effectiveness of investigational cancer drug nivolumab

People with Merkel cell, gynecological, gastric and head and neck cancers may be eligible to participate in a clinical trial at Sanford Health testing the effectiveness of an investigational drug called nivolumab.

18 Feb 2016

New treatment protects mice from MERS infection

In a new study, University of Maryland School of Medicine researchers have had promising results with a new treatment for Middle East Respiratory Syndrome (MERS). The study, published today in the journal Science Translational Medicine, found a new treatment that protected mice from MERS infection.

18 Feb 2016

FDA issues new guidance to reduce risk of Zika blood transmission

As a safety measure against the emerging Zika virus outbreak, today the U.S. Food and Drug Administration issued a new guidance recommending the deferral of individuals from donating blood if they have been to areas with active Zika virus transmission, potentially have been exposed to the virus, or have had a confirmed Zika virus infection.

18 Feb 2016

WRAIR begins Phase 1 clinical trial to evaluate MERS vaccine candidate

The Walter Reed Army Institute of Research began vaccinations today in a Phase 1 clinical trial to evaluate the safety and immune response of a vaccine candidate to prevent Middle East Respiratory Syndrome (MERS).

17 Feb 2016

New staging system proposed to identify most appropriate treatments for HPV-related OPC

Human papillomavirus (HPV) status is a strong predictor of prognosis for patients with oropharyngeal carcinoma (OPC), but the current staging system does not adequately account for biological and clinical differences between HPV-positive OPC and HPV-negative OPC, commonly caused by alcohol and tobacco use.

17 Feb 2016

Zika virus isn't stopping Americans from making international travel plans, study finds

Global concerns about Zika virus aren't stopping Americans from making international travel plans, a new study finds, but many who do plan to go abroad say they want more information about the virus.

17 Feb 2016

Electronic health records could help identify people who have undiagnosed type 2 diabetes

In 2012, a group of UCLA researchers set out to mine thousands of electronic health records for a more accurate and less expensive way to identify people who have undiagnosed type 2 diabetes. The researchers got much more than they bargained for.

16 Feb 2016

UAB research reveals heterogonous population of leukemia stem cells

University of Alabama at Birmingham researchers have found a marker on blood cells that may help the most pressing problem in chronic myelogenous leukemia, or CML, today — an inability to get patients off treatment.

16 Feb 2016

NAU researcher calls for greater public awareness of cytomegalovirus

As the Zika virus continues to spread across the globe, and gain worldwide attention for its' potential birth defects, an NAU researcher is calling for greater public awareness of cytomegalovirus—the most common viral cause of birth defects in the United States.

16 Feb 2016

Johns Hopkins experts provide useful information to help prevent transmission of Zika virus

With Zika virus emerging as a public health concern worldwide, experts at The Johns Hopkins Hospital are closely monitoring the spread of the mosquito-borne illness and offering useful information to help prevent transmission.

16 Feb 2016

CMV-based vaccine provides protection against Ebola virus

As the latest in a series of studies, researchers at Plymouth University, National Institutes of Health and University of California, Riverside, have shown the ability of a vaccine vector based on a common herpesvirus called cytomegalovirus (CMV) expressing Ebola virus glycoprotein (GP), to provide protection against Ebola virus in the experimental rhesus macaque, non-human primate (NHP) model.

16 Feb 2016

Experimental vaccine shows effectiveness in Ebola vaccine trial

An experimental vaccine combined with an innovative way of vaccinating people has resulted in an estimated 100 percent efficacy of the vaccine against the Ebola virus in West Africa -- and the approach could establish a new way of responding to outbreaks of emerging pathogens, including the Zika virus.

16 Feb 2016

RB announces Zika Relief Package of $1 million to help fight Zika virus outbreak

In response to the global call for urgently needed resources to fight the spread of the Zika virus, RB is announcing a Zika Relief Package of $1 million USD consisting of both cash and product donations that will be made available to health authorities and international NGOs battling the outbreak.

16 Feb 2016

UF study shows effective way to control damaging health impacts of mosquito-borne diseases

A common toxin used to kill yellow fever mosquito larvae - the most prevalent transmitter of dengue, chikungunya and zika viruses - is highly effective. While there are some fitness advantages to surviving adults, this is still an effective way to control the damaging health impacts of these mosquito-borne diseases, a new University of Florida study shows.

15 Feb 2016

Virology News and Research

Latest Virology News and Research

DEK gene present in plasma can help predict outcomes for patients with head and neck cancer

Revealing dynamic protein complexes with NMR: an interview with Elisar Barbar

Zika virus can cross the placental barrier, according to new study

Sanford Health clinical trial testing effectiveness of investigational cancer drug nivolumab

New treatment protects mice from MERS infection

FDA issues new guidance to reduce risk of Zika blood transmission

WRAIR begins Phase 1 clinical trial to evaluate MERS vaccine candidate

New staging system proposed to identify most appropriate treatments for HPV-related OPC

Zika virus isn't stopping Americans from making international travel plans, study finds

Electronic health records could help identify people who have undiagnosed type 2 diabetes

UAB research reveals heterogonous population of leukemia stem cells

NAU researcher calls for greater public awareness of cytomegalovirus

Johns Hopkins experts provide useful information to help prevent transmission of Zika virus

CMV-based vaccine provides protection against Ebola virus

Experimental vaccine shows effectiveness in Ebola vaccine trial

RB announces Zika Relief Package of $1 million to help fight Zika virus outbreak

UF study shows effective way to control damaging health impacts of mosquito-borne diseases

Wake Forest Baptist researchers develop new nanotechnology to detect disease biomarkers

Scientists modify plants' defense system to confer resistance to virus

Tick genome study sheds light on occurrences of Lyme disease

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production